Kasabach-Merritt syndrome in children
Kasabach-Merritt syndrome is a combination of thrombocytopenia, intravascular coagulation, and a rapid increase in the size of an angioma. Anemia and disseminated intravascular coagulation may develop. This infrequent syndrome is severe and may be life-threatening. Pathophysiologic mechanisms underlying the condition are incompletely understood and, consequently, many different treatments are used, including systemic corticosteroids, compression, embolization, antifibrinolytic agents, platelet aggregation inhibitors, irradiation, and others. From findings in eight personal cases, the authors review clinical and biological features, pathophysiologic hypotheses and therapeutic strategies.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
1992 |
---|---|
Erschienen: |
1992 |
Enthalten in: |
Zur Gesamtaufnahme - volume:39 |
---|---|
Enthalten in: |
Annales de pediatrie - 39(1992), 7 vom: 13. Sept., Seite 435-41 |
Sprache: |
Französisch |
---|
Weiterer Titel: |
Syndrome de Kasabach-Merritt de l'enfant |
---|
Beteiligte Personen: |
Teillac-Hamel, D [VerfasserIn] |
---|
Themen: |
Aspirin |
---|
Anmerkungen: |
Date Completed 25.11.1992 Date Revised 21.11.2013 published: Print Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM013981072 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM013981072 | ||
003 | DE-627 | ||
005 | 20231221060119.0 | ||
007 | tu | ||
008 | 231221s1992 xx ||||| 00| ||fre c | ||
028 | 5 | 2 | |a pubmed24n0047.xml |
035 | |a (DE-627)NLM013981072 | ||
035 | |a (NLM)1416665 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a fre | ||
100 | 1 | |a Teillac-Hamel, D |e verfasserin |4 aut | |
245 | 1 | 0 | |a Kasabach-Merritt syndrome in children |
246 | 3 | 3 | |a Syndrome de Kasabach-Merritt de l'enfant |
264 | 1 | |c 1992 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Completed 25.11.1992 | ||
500 | |a Date Revised 21.11.2013 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Kasabach-Merritt syndrome is a combination of thrombocytopenia, intravascular coagulation, and a rapid increase in the size of an angioma. Anemia and disseminated intravascular coagulation may develop. This infrequent syndrome is severe and may be life-threatening. Pathophysiologic mechanisms underlying the condition are incompletely understood and, consequently, many different treatments are used, including systemic corticosteroids, compression, embolization, antifibrinolytic agents, platelet aggregation inhibitors, irradiation, and others. From findings in eight personal cases, the authors review clinical and biological features, pathophysiologic hypotheses and therapeutic strategies | ||
650 | 4 | |a Case Reports | |
650 | 4 | |a English Abstract | |
650 | 4 | |a Journal Article | |
650 | 7 | |a Ticlopidine |2 NLM | |
650 | 7 | |a OM90ZUW7M1 |2 NLM | |
650 | 7 | |a Aspirin |2 NLM | |
650 | 7 | |a R16CO5Y76E |2 NLM | |
650 | 7 | |a Pentoxifylline |2 NLM | |
650 | 7 | |a SD6QCT3TSU |2 NLM | |
650 | 7 | |a Prednisone |2 NLM | |
650 | 7 | |a VB0R961HZT |2 NLM | |
700 | 1 | |a Andry, P |e verfasserin |4 aut | |
700 | 1 | |a Bodemer, C |e verfasserin |4 aut | |
700 | 1 | |a Hubert, P |e verfasserin |4 aut | |
700 | 1 | |a Sebag, G |e verfasserin |4 aut | |
700 | 1 | |a Brunelle, F |e verfasserin |4 aut | |
700 | 1 | |a Nihoul-Fékété, C |e verfasserin |4 aut | |
700 | 1 | |a de Prost, Y |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annales de pediatrie |d 1959 |g 39(1992), 7 vom: 13. Sept., Seite 435-41 |w (DE-627)NLM000963259 |x 0066-2097 |7 nnns |
773 | 1 | 8 | |g volume:39 |g year:1992 |g number:7 |g day:13 |g month:09 |g pages:435-41 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 39 |j 1992 |e 7 |b 13 |c 09 |h 435-41 |